Compare Stocks: OFIX, MMSI, CNMD, and ENOV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$47.58 +3.3%	$47.54	$31.44 ▼ $53.66	$1.38B	0.94	380,914 shs	440,153 shs
ENOV Enovis	$20.67 +4.0%	$20.57	$16.70 ▼ $34.28	$1.15B	1.37	1.44 million shs	1.18 million shs
MMSI Merit Medical Systems	$91.18 +1.4%	$88.30	$59.74 ▼ $94.75	$5.37B	0.51	620,169 shs	688,801 shs
OFIX Orthofix Medical	$9.85 +2.7%	$9.44	$8.50 ▼ $16.99	$390.63M	0.62	425,908 shs	335,289 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-0.84%	+1.96%	+1.66%	+10.20%	+2.37%
ENOV Enovis	+1.60%	+9.19%	+10.53%	-26.32%	-36.55%
MMSI Merit Medical Systems	+0.85%	+0.23%	+5.38%	+22.43%	+9.89%
OFIX Orthofix Medical	+2.24%	+3.34%	+10.10%	-17.54%	-36.32%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$47.58 +3.3%	$47.54	$31.44 ▼ $53.66	$1.38B	0.94	380,914 shs	440,153 shs
ENOV Enovis	$20.67 +4.0%	$20.57	$16.70 ▼ $34.28	$1.15B	1.37	1.44 million shs	1.18 million shs
MMSI Merit Medical Systems	$91.18 +1.4%	$88.30	$59.74 ▼ $94.75	$5.37B	0.51	620,169 shs	688,801 shs
OFIX Orthofix Medical	$9.85 +2.7%	$9.44	$8.50 ▼ $16.99	$390.63M	0.62	425,908 shs	335,289 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-0.84%	+1.96%	+1.66%	+10.20%	+2.37%
ENOV Enovis	+1.60%	+9.19%	+10.53%	-26.32%	-36.55%
MMSI Merit Medical Systems	+0.85%	+0.23%	+5.38%	+22.43%	+9.89%
OFIX Orthofix Medical	+2.24%	+3.34%	+10.10%	-17.54%	-36.32%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	1.75	Reduce	$41.40	-12.99% Downside
ENOV Enovis	2.75	Moderate Buy	$37.25	80.20% Upside
MMSI Merit Medical Systems	2.83	Moderate Buy	$100.00	9.67% Upside
OFIX Orthofix Medical	2.40	Hold	$14.75	49.75% Upside

Current Analyst Ratings Breakdown

Latest OFIX, MMSI, CNMD, and ENOV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/16/2026	ENOV Enovis	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/12/2026	MMSI Merit Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C) ➝ Hold (C+)
10/12/2026	ENOV Enovis	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$52.00 ➝ $34.00
10/6/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C-) ➝ Sell (D+)
10/5/2026	ENOV Enovis	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$44.00
10/2/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/29/2026	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$101.00
9/17/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D+) ➝ Hold (C-)
9/11/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/2/2026	ENOV Enovis	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Market Outperform
9/2/2026	ENOV Enovis	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Overweight	$39.00 ➝ $33.00

(Data available from 10/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.37B	1.04	$7.45 per share	6.39	$33.36 per share	1.43
ENOV Enovis	$2.25B	0.53	$27.93 per share	0.74	$26.09 per share	0.79
MMSI Merit Medical Systems	$1.52B	3.59	$5.96 per share	15.30	$26.72 per share	3.41
OFIX Orthofix Medical	$822.31M	0.49	N/A	N/A	$11.30 per share	0.87

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$47.06M	$1.85	25.72	10.06	2.10	4.12%	14.31%	6.33%	10/28/2026 (Confirmed)
ENOV Enovis	-$1.18B	-$19.26	5.93	6.71	N/A	-47.96%	12.03%	4.91%	11/5/2026 (Estimated)
MMSI Merit Medical Systems	$128.49M	$2.42	24.51	21.87	2.25	9.22%	13.75%	8.10%	10/29/2026 (Estimated)
OFIX Orthofix Medical	-$92.19M	-$1.54	N/A	N/A	N/A	-7.41%	-14.05%	-7.17%	11/3/2026 (Estimated)

Latest OFIX, MMSI, CNMD, and ENOV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	ENOV Enovis	$0.7670	N/A	N/A	N/A	$557.15 million	N/A
11/3/2026	Q3 2026	OFIX Orthofix Medical	$0.11	N/A	N/A	N/A	$210.52 million	N/A
10/29/2026	Q3 2026	MMSI Merit Medical Systems	$1.04	N/A	N/A	N/A	$410.34 million	N/A
10/28/2026	Q3 2026	CNMD CONMED	$1.00	N/A	N/A	N/A	$336.28 million	N/A
8/6/2026	Q2 2026	ENOV Enovis	$0.8470	$0.90	+$0.0530	-$0.02	$581.84 million	$582.78 million
8/5/2026	Q2 2026	OFIX Orthofix Medical	-$0.4099	-$0.39	+$0.0199	-$0.39	$209.28 million	$210.93 million
7/30/2026	Q2 2026	MMSI Merit Medical Systems	$0.9590	$1.19	+$0.2310	$0.65	$405.25 million	$418.84 million
7/29/2026	Q2 2026	CNMD CONMED	$1.11	$1.38	+$0.27	$0.77	$337.60 million	$343.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	N/A	N/A	-5.59%	N/A	N/A
ENOV Enovis	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.63	1.48	0.69
ENOV Enovis	0.84	1.98	1.00
MMSI Merit Medical Systems	0.44	4.20	2.79
OFIX Orthofix Medical	0.55	2.84	1.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
ENOV Enovis	98.45%
MMSI Merit Medical Systems	99.66%
OFIX Orthofix Medical	89.76%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	0.28%
ENOV Enovis	2.90%
MMSI Merit Medical Systems	0.70%
OFIX Orthofix Medical	2.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	29.95 million	29.87 million	Optionable
ENOV Enovis	7,802	57.67 million	56.00 million	Optionable
MMSI Merit Medical Systems	7,500	59.71 million	59.29 million	Optionable
OFIX Orthofix Medical	1,605	40.73 million	39.63 million	Optionable

OFIX, MMSI, CNMD, and ENOV Headlines

Recent News About These Companies

Orthofix Medical stock posts USD 0.39 loss per share in second quarter

October 19 at 6:49 PM | ad-hoc-news.deA

Five analysts set USD 14.75 target for Orthofix Medical stock

October 15, 2026 | ad-hoc-news.deA

Five analysts set USD 14.75 target for Orthofix Medical stock

October 15, 2026 | ad-hoc-news.deA

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

October 13, 2026 | prnewswire.com

Orthofix pays former executives $24M in damages

October 12, 2026 | finance.yahoo.com

Orthofix Medical Inc. (NASDAQ:OFIX) Stock Has Consensus Price Target of $14.75 According to Brokerages

October 11, 2026 | americanbankingnews.com

Orthofix Medical Inc. (NASDAQ:OFIX) Stock Has Consensus Price Target of $14.75

October 11, 2026 | marketbeat.com

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 44.44% Potential Upside Amidst Healthcare Innovation

October 9, 2026 | directorstalkinterviews.com

Canaccord cuts target for Orthofix Medical stock from USD 18.00 to USD 13.00

October 8, 2026 | ad-hoc-news.deA

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)

October 8, 2026 | prnewswire.com

Orthofix Medical stock gains on Q2 revenue beat

October 5, 2026 | ad-hoc-news.deA

Bank of America Corp DE Buys New Holdings in Orthofix Medical Inc. $OFIX

October 1, 2026 | marketbeat.com

Orthofix Medical stock reports USD 210.93 million revenue

September 30, 2026 | ad-hoc-news.deA

Juniper Investment vende azioni Orthofix Medical per $2,73 mln

September 29, 2026 | it.investing.com

Former Orthofix Execs Fired Over Tawdry Texts Awarded $24.5M

September 24, 2026 | law.comL

Orthofix Medical stock holds near its yearly low

September 22, 2026 | ad-hoc-news.deA

Stifel维持Orthofix Medical买入评级，目标价$13

September 16, 2026 | cn.investing.com

Orthofix Medical (NASDAQ:OFIX) Insider Patrick Fisher Sells 1,295 Shares of Stock

August 21, 2026 | insidertrades.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (OFIX), Rhythm Pharmaceuticals (RYTM) and Viatris (VTRS)

August 11, 2026 | theglobeandmail.com

Orthofix raises 2026 outlook after Q2 sales growth

August 6, 2026 | beckersspine.comB

Orthofix: Q2 Earnings Snapshot

August 5, 2026 | houstonchronicle.comH

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX, MMSI, CNMD, and ENOV Company Descriptions

CONMED NYSE:CNMD

$47.58 +1.53 (+3.32%)

Closing price 03:59 PM Eastern

Extended Trading

$47.58 0.00 (0.00%)

As of 04:33 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Enovis NYSE:ENOV

$20.67 +0.80 (+4.03%)

Closing price 03:59 PM Eastern

Extended Trading

$20.68 +0.01 (+0.07%)

As of 07:04 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Merit Medical Systems NASDAQ:MMSI

$91.18 +1.22 (+1.36%)

Closing price 04:00 PM Eastern

Extended Trading

$91.18 0.00 (0.00%)

As of 05:20 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Orthofix Medical NASDAQ:OFIX

$9.85 +0.26 (+2.71%)

Closing price 04:00 PM Eastern

Extended Trading

$9.85 0.00 (-0.05%)

As of 04:01 PM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OFIX, MMSI, CNMD, and ENOV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OFIX, MMSI, CNMD, and ENOV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OFIX, MMSI, CNMD, and ENOV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX, MMSI, CNMD, and ENOV Company Descriptions

CONMED NYSE:CNMD

Enovis NYSE:ENOV

Merit Medical Systems NASDAQ:MMSI

Orthofix Medical NASDAQ:OFIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OFIX, MMSI, CNMD, and ENOV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OFIX, MMSI, CNMD, and ENOV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OFIX, MMSI, CNMD, and ENOV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX, MMSI, CNMD, and ENOV Company Descriptions

CONMED NYSE:CNMD

Enovis NYSE:ENOV

Merit Medical Systems NASDAQ:MMSI

Orthofix Medical NASDAQ:OFIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools